Newsroom

For the latest team, company and product news from Huma

Newsroom

For the latest team, company and product news from Huma

Press Releases

Media Coverage

2026

Huma Therapeutics Launches Huma Intelligence Scribe Powered by NVIDIA AI Technology

2025

Huma Deploys Hi Scribe to Automate Clinical Documentation and Billing Using AI

Huma Announces Partnership with Eckuity Capital to Accelerate M&A and Acquires Aluna

Huma Therapeutics Receives Health Canada Class II Medical Device License for Huma Cloud Platform

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

Huma and Wheel partner to deliver a Direct-to-Consumer Platform as a Service

Samsung, Huma and Tulane University’s HEARTBEAT 10,000 Study Enrolls First Patient

2024

Huma acquires eConsult and launches Huma Workspace for Health Systems

Huma Launches App to Support Patients with Glioma

Huma Secures Clearance for Class C Medical Device Certification in India

Eczacibasi Evital and Huma collaborate in digital health

Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital-first care and research to everyone

Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia

Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients

2023

Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform

Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care

Huma collaborates with Google Cloud to improve healthcare through generative AI

Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform

Huma named for its successful and innovative approach to clinical trials in new UK government review

UCB and Huma partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis

Huma receives world’s first and only multi-condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform

How our Huma app drives engagement in population health research

Largest decentralised study of its kind shows high levels of engagement with Huma’s study app

Huma acquires Alcedis, one of the world's leading digital clinical trials companies

2022

Keeping patients safe at home with virtual wards

Increasing clinical trial success rates with adaptive technology

Fixing the foundations: building a solid evidence base for digital health

How to design virtual wards: 5 tips to set you up for success

How Huma technology can reduce burnout on virtual wards

Press Releases

Media Coverage

2026

Huma Therapeutics Launches Huma Intelligence Scribe Powered by NVIDIA AI Technology

2025

Huma Deploys Hi Scribe to Automate Clinical Documentation and Billing Using AI

Huma Announces Partnership with Eckuity Capital to Accelerate M&A and Acquires Aluna

Huma Therapeutics Receives Health Canada Class II Medical Device License for Huma Cloud Platform

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

Huma and Wheel partner to deliver a Direct-to-Consumer Platform as a Service

Samsung, Huma and Tulane University’s HEARTBEAT 10,000 Study Enrolls First Patient

2024

Huma acquires eConsult and launches Huma Workspace for Health Systems

Huma Launches App to Support Patients with Glioma

Huma Secures Clearance for Class C Medical Device Certification in India

Eczacibasi Evital and Huma collaborate in digital health

Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital-first care and research to everyone

Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia

Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients

2023

Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform

Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care

Huma collaborates with Google Cloud to improve healthcare through generative AI

Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform

Huma named for its successful and innovative approach to clinical trials in new UK government review

UCB and Huma partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis

Huma receives world’s first and only multi-condition EU MDR Class IIb regulatory approval for its configurable SaMD disease management platform

How our Huma app drives engagement in population health research

Largest decentralised study of its kind shows high levels of engagement with Huma’s study app

Huma acquires Alcedis, one of the world's leading digital clinical trials companies

2022

Keeping patients safe at home with virtual wards

Increasing clinical trial success rates with adaptive technology

Fixing the foundations: building a solid evidence base for digital health

How to design virtual wards: 5 tips to set you up for success

How Huma technology can reduce burnout on virtual wards

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more

Press enquiries:

press@huma.com